ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002

Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies.

April 30, 2004

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS

June 7, 1985

Cancer Panel Report Urges Removal Of Barriers To Care.

December 7, 2001

NCI Cooperative Group Clinical Trials Approved

October 30, 2009